These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11184997)

  • 21. Mitochondrial complex I inhibitor rotenone-induced toxicity and its potential mechanisms in Parkinson's disease models.
    Xiong N; Long X; Xiong J; Jia M; Chen C; Huang J; Ghoorah D; Kong X; Lin Z; Wang T
    Crit Rev Toxicol; 2012 Aug; 42(7):613-32. PubMed ID: 22574684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Edaravone-caffeine combination for the effective management of rotenone induced Parkinson's disease in rats: An evidence based affirmative from a comparative analysis of behavior and biomarker expression.
    Bandookwala M; Sahu AK; Thakkar D; Sharma M; Khairnar A; Sengupta P
    Neurosci Lett; 2019 Oct; 711():134438. PubMed ID: 31422100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotection by valproic acid in an intrastriatal rotenone model of Parkinson's disease.
    Carriere CH; Kang NH; Niles LP
    Neuroscience; 2014 May; 267():114-21. PubMed ID: 24613722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats.
    Alam M; Schmidt WJ
    Behav Brain Res; 2004 Aug; 153(2):439-46. PubMed ID: 15265640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rotenone potentiates dopamine neuron loss in animals exposed to lipopolysaccharide prenatally.
    Ling Z; Chang QA; Tong CW; Leurgans SE; Lipton JW; Carvey PM
    Exp Neurol; 2004 Dec; 190(2):373-83. PubMed ID: 15530876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of novel proteins affected by rotenone in mitochondria of dopaminergic cells.
    Jin J; Davis J; Zhu D; Kashima DT; Leroueil M; Pan C; Montine KS; Zhang J
    BMC Neurosci; 2007 Aug; 8():67. PubMed ID: 17705834
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: relevance to Parkinson's disease.
    Hartley A; Stone JM; Heron C; Cooper JM; Schapira AH
    J Neurochem; 1994 Nov; 63(5):1987-90. PubMed ID: 7931358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular pathways of neurodegeneration in Parkinson's disease.
    Dawson TM; Dawson VL
    Science; 2003 Oct; 302(5646):819-22. PubMed ID: 14593166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rotenone-induced parkinsonism elicits behavioral impairments and differential expression of parkin, heat shock proteins and caspases in the rat.
    Sonia Angeline M; Chaterjee P; Anand K; Ambasta RK; Kumar P
    Neuroscience; 2012 Sep; 220():291-301. PubMed ID: 22710069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative study of mitochondrial complex I in platelets of parkinsonian patients.
    Blandini F; Nappi G; Greenamyre JT
    Mov Disord; 1998 Jan; 13(1):11-5. PubMed ID: 9452319
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial regulation by pyrroloquinoline quinone prevents rotenone-induced neurotoxicity in Parkinson's disease models.
    Lu J; Chen S; Shen M; He Q; Zhang Y; Shi Y; Ding F; Zhang Q
    Neurosci Lett; 2018 Nov; 687():104-110. PubMed ID: 30240821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enteric Neurodegeneration is Mediated Through Independent Neuritic and Somal Mechanisms in Rotenone and MPP+ Toxicity.
    Virga DM; Capps J; Vohra BPS
    Neurochem Res; 2018 Dec; 43(12):2288-2303. PubMed ID: 30259276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity.
    Ying R; Liang HL; Whelan HT; Eells JT; Wong-Riley MT
    Brain Res; 2008 Dec; 1243():167-73. PubMed ID: 18848925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blockade of metabotropic glutamate receptor 5 protects against DNA damage in a rotenone-induced Parkinson's disease model.
    Xia N; Zhang Q; Wang ST; Gu L; Yang HM; Liu L; Bakshi R; Yang H; Zhang H
    Free Radic Biol Med; 2015 Dec; 89():567-80. PubMed ID: 26454081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ameliorative effect of Sida cordifolia in rotenone induced oxidative stress model of Parkinson's disease.
    Khurana N; Gajbhiye A
    Neurotoxicology; 2013 Dec; 39():57-64. PubMed ID: 23994302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The behavioural and neuropathological impact of intranigral AAV-α-synuclein is exacerbated by systemic infusion of the Parkinson's disease-associated pesticide, rotenone, in rats.
    Mulcahy P; O'Doherty A; Paucard A; O'Brien T; Kirik D; Dowd E
    Behav Brain Res; 2013 Apr; 243():6-15. PubMed ID: 23295396
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial mitochondrial complex I inhibition induces oxidative damage and perturbs glutamate transport in primary retinal cultures. Relevance to Leber Hereditary Optic Neuropathy (LHON).
    Beretta S; Wood JP; Derham B; Sala G; Tremolizzo L; Ferrarese C; Osborne NN
    Neurobiol Dis; 2006 Nov; 24(2):308-17. PubMed ID: 16959493
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that the blockade of mitochondrial respiration by the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) involves binding at the same site as the respiratory inhibitor, rotenone.
    Krueger MJ; Singer TP; Casida JE; Ramsay RR
    Biochem Biophys Res Commun; 1990 May; 169(1):123-8. PubMed ID: 2350337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of Aging in the Striatum and Substantia Nigra of a Parkinson's Disease Animal Model.
    Ureshino RP; Costa AJ; Erustes AG; Pereira GJDS; Sinigaglia-Coimbra R; Smaili SS
    Toxicol Pathol; 2018 Apr; 46(3):348-358. PubMed ID: 29683090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclin-dependent kinase 5-mediated phosphorylation of CHIP promotes the tAIF-dependent death pathway in rotenone-treated cortical neurons.
    Kim C; Lee J; Ko YU; Oh YJ
    Neurosci Lett; 2018 Jan; 662():295-301. PubMed ID: 29111393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.